Reimagining cancer research through innovation and collaboration πβ
β
Vivan Therapeutics and Imaging Biometrics, LLC announce a strategic partnership to advance new cancer treatments using Gallium Maltolate.β
β
The two biotech innovators will leverage Vivanβs cutting-edge in vivo high-throughput screening platform to explore new oncologic indications for Gallium Maltolate,Β a compound that has already shown promise in glioblastoma.β